Erfindergemeinschaft UroPep GbR v. Eli Lilly and Company et al, No. 2:15-cv-01202 (E.D. Tex. Mar. 17, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Defendant Eli Lilly & Company (“Lilly”) has filed a Corrected Motion to Exclude Certain Opinions of UroP ep’s Damages and Technical Experts . Dkt. No. 223 (“Lilly’s Motion to Exclude”). Following briefing, Dkt. Nos. 223, 184, 199 & 221, the Court heard argument on Lilly’s motion on February 21, 2017. The motion is DENIED as to Drs. Bell and Vellturo, and GRANTED IN PART and DENIED IN PART as to Dr. Sliwinski, as explained below. BACKGROUND Plaintiff Erfindergemeinschaft UroPep GbR (“UroPep”) initiated this action against Lilly for infringing U.S.